TECO Treaty Energy Corporation

Breaking Ground in the Fight Against Huntington's The latest shuffle in the relentless pursuit of medical breakthroughs sees Skyhawk Therapeutics rolling their dice in the fight against Huntington's disease (HD) with the U.S. launch of their pivotal FALCON-HD study. HD is a treacherous, progressive disorder that’s been stealing time from patients for far too long. It's...

Solid Earnings in a Challenging Market Anytime you start hearing a company like PPL boasting about their quarterly earnings, it's time to sit up straight and pay attention. The utility giant didn’t just match expectations, they beat 'em, clocking in with $0.54 per share in ongoing earnings for Q3 2026, up from $0.48 the previous year. Not a bad step forward if you ask...

Reassessing Bonds Post-2026 Midterms When the election circus packs up its tents, investors like us are left standing in the wreckage, trying to figure out what's next for our portfolios. That's just where One Oak Capital Management's latest research fits into our jigsaw—exploring how the political winds can ripple through the layers of the bond market. Federal...

All Eyes on Curis as Q3 Financials Loom Just when you think you’ve seen it all in this wild biotech ride, Curis, Inc. (NASDAQ: CRIS) is prepping to roll out their third quarter financial and operating results. Circle your calendars for November 12, 2026, because the clock’s ticking down to their 4:00 p.m. ET announcement, swiftly followed by a conference call at 4:30...

A Standout Quarter for Senstar Technologies How often do you see a company jumping 37% in revenue year-over-year? Not every day, that’s for sure. But that's exactly what's happening with Senstar Technologies Corporation (NASDAQ: SNT). For the third quarter of 2026, they've pulled in $13.1 million compared to last year’s $9.5 million. And that's not just some fluke –...

Voices Raised Against a Corporate Giant Today, outside the drab halls of the Virginia State Corporation Commission (SCC), a group of faith leaders drew a line in the sand against a looming energy giant. The $67 billion move to merge Dominion Energy with NextEra Energy ignited their rallying cry. Phooey to sacrificing community well-being for corporate greed, they shouted....

The Lowdown on Ensign's Recent Troubles Alright, folks, here's the scoop that might have you reaching for the Maalox. If you've put your chips on The Ensign Group, Inc. (NASDAQ: ENSG), you might want to keep your eyes peeled. Schall, Brown & Schwartz LLP—or SBS, as the pros call 'em—is ringing the alarm bells with a securities fraud suit that's got the potential to...

In the churn of Wall Street, every now and then a company's stock ticker takes center stage for all the wrong reasons. The latest contender under the harsh spotlight is none other than D-Wave Quantum Inc. (NASDAQ: QBTS). They're finding themselves marooned in hot water over allegations of securities fraud, which might just send investors scrambling like sand crabs at high...

Lawsuit at Webull: What's for Real Here? Nobody likes the sound of lawsuits, least of all investors. And yet, here we are with Webull Corporation caught in the crosshairs of a class action lawsuit. Claims have popped up that the company's been spinning tales more outlandish than the opening pitch of a penny stock—they stand accused of misleading statements that might...

A Step Closer for Zemprocitinib: Here's the Lowdown Surprise in the pharma skies as Lynk Pharmaceuticals takes a major leap with its new gem, zemprocitinib, entering the regulatory review phase. The center buzzed on November 4 when China's NMPA gave the coveted nod to this New Drug Application (NDA). Seems the race for rheumatoid arthritis (RA) treatments just got a...

Director's Stock Purchase at Americas CarMart Americas CarMart Inc. (NASDAQ: CRMT) has recently caught the public's attention as director Ann G. Bordelon purchased shares worth $52,976. This acquisition signals a strong confidence in the used car dealership's ability to face the competitive market and continue on its path toward growth and success. The Acquisition Details...

Scully Royalty Ltd. Half-Year Financial Report Insights Scully Royalty Ltd. (NYSE: SRL) has recently published its half-year report, detailing its financial results for the six months concluded. The report, referred to as the Half-Year Report, reflects the company's business performance and strategic updates. Dividend Declaration and Financial Performance In conjunction...

Inozyme Pharma's Strategic Vision for 2024 Inozyme Pharma, Inc. (NASDAQ: INZY) is making significant strides as it navigates the dynamic landscape of biotechnology. The company specializes in developing breakthrough therapeutics tailored for rare diseases impacting bone health and vascular function. As of December 31, 2024, Inozyme announced its financial results...

Strategy Inc and Snowflake Team Up for Enhanced Data Management Strategy Inc (NASDAQ: MSTR) has announced its partnership with Snowflake Inc (NYSE: SNOW) to establish a more standardized framework for managing data effectively. This collaboration aims to simplify and streamline the data landscape through the Open Semantic Interchange (OSI) Advancing Open Data Standards As...

Innovative Industrial Properties Legal Challenges Shareholders of Innovative Industrial Properties, Inc. (NYSE: IIPR) are currently navigating a troubling period as the company faces a lawsuit for securities law violations. This situation raises important questions for investors who may be affected. Class Period and Allegations The allegations against IIPR highlight...